Document is current
Any future updates will be listed below
-
Authors
Davenport, Mackenzie L.
Fong, Amaya
Albury, Kaela N.
Henley-Beasley, C. Spencer
Barton, Elisabeth R.
Maden, Malcolm
Swanson, Maurice S.
-
Funding
Funding for this research was provided by:
Myotonic Dystrophy Foundation (P0293458)
National Institutes of Health (P50 AR052646, P50 NS048843)
- License Information
-
More Information
Article History
Received: 10 July 2024
Accepted: 20 October 2024
First Online: 29 October 2024
Declarations
:
: All animal procedures were conducted in accordance with National Institutes of Health Guidelines and approved by the Institutional Animal Care and Use Committee (IACUC) at the University of Florida (protocol numbers 202107707 for <i>A. cahirinus</i> studies and 20203677 for <i>M. musculus</i> studies).
: Not applicable.
: M.S.S. is a Scientific Advisory Board member for Skyhawk Therapeutics and Tacit Therapeutics.
